Try our Advanced Search for more refined results
Macleods Pharmaceuticals Ltd.
-
Trial | Filed: June 07, 2024 | Entered: June 07, 2024 In re: Entresto (Sacubitril/Valsartan) Patent Litigation
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Post Trial Brief
POST TRIAL BRIEF Plaintiff's Reply Post-Trial Brief on Hetero's and Torrent's Infringement of U.S. Patent No. 11,058,667 by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra)
-
Trial | Filed: June 07, 2024 | Entered: June 07, 2024 Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Post Trial Brief
POST TRIAL BRIEF Defendants' Post Trial Reply Brief on Invalidity of the '918 and '667 Patents by Torrent Pharma Inc., Torrent Pharmaceuticals Ltd.. (Taylor, Daniel)
-
Trial | Filed: June 07, 2024 | Entered: June 07, 2024 In re: Entresto (Sacubitril/Valsartan) Patent Litigation
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Post Trial Brief
POST TRIAL BRIEF Defendants' Post Trial Reply Brief on Invalidity of the '918 and '667 Patents by Torrent Pharma Inc., Torrent Pharmaceuticals Ltd.. (Taylor, Daniel)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login